WHO ICTRP trial
Prophylactic effect of mirtazapine for carboplatin-induced nausea and vomiting
JPRN-jRCTs041220042 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs041220042 |
|---|---|
| Public title | Prophylactic effect of mirtazapine for carboplatin-induced nausea and vomiting |
| Scientific title | Efficacy and safety of mirtazapine combined with granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in thoracic cancer patients: A multi-institution phase II study |
| Primary sponsor | Endo Junki |
| Secondary sponsors | Suzuki Akio |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Thoracic cancer Thoracic Neoplasms;D013899;Thoracic Neoplasms |
| Interventions | All patients received granisetron (1mg intravenous infusion on day 1, 30 min before chemotherapy), dexamethasone (9.9mg intravenous infusion or 12 mg oral administration on day 1, 6.6 mg intravenous infusion or 8 mg oral administration on… |
| Registration date | Jul 13, 2022 |
| Target size | 51 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: